Oscar Gruss Issues Speculative BUY on Cypress Bioscience, Inc. Common --see note a
Oscar Gruss Issues Speculative BUY on Cypress Bioscience, Inc. Common --see note a
About this item
Full title
Author / Creator
Publisher
New York: Business Wire
Journal title
Language
English
Formats
Publication information
Publisher
New York: Business Wire
More information
Scope and Contents
Contents
(BUSINESS WIRE)--March 20, 1997--Oscar Gruss & Son Incorporated, has initiated coverage of Cypress Bioscience, Inc., San Diego, CA, with a Speculative BUY recommendation. (NASDAQ: CYPB). Cypress Bioscience, Inc., researches, develops, manufactures, and markets medical devices and therapeutics for immune diseases and is developing a novel platelet s...
Alternative Titles
Full title
Oscar Gruss Issues Speculative BUY on Cypress Bioscience, Inc. Common --see note a
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_446963852
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_446963852